OTC · Medical - Pharmaceuticals

Alibaba Health Information Technology Limited (ALBBY) Stock

$8.60 -7.63% OTC: ALBBY Healthcare

Alibaba Health Information Technology Limited, an investment holding entity based in Causeway Bay, Hong Kong, manages a diverse range of operations across Mainland China and Hong Kong. Its core business revolves around pharmaceutical retail, operating an extensive e-commerce platform for health-related goods, and delivering a broad spectrum of digital healthcare services.

Valuation

MetricValue
Price$8.60
Market Cap$6.93B
P/E Ratio24.56
P/B Ratio2.68
P/S Ratio1.39
EPS (TTM)$0.35
52-Week High$19.45
52-Week Low$7.83
Dividend Yield0.00%

Financials & Margins

MetricValue
ROE10.95%
ROA8.41%
ROCE10.24%
Gross Margin23.97%
Operating Margin5.36%
Net Margin5.65%
Debt/Equity0.00
Current Ratio3.03

Annual Financials (USD)

Metric20222023202420252026
Revenue$20.6B$26.8B$27.0B$30.6B$33.2B
Operating Profit$-1.1B$-32.0M$640.0M$1.6B$1.8B
Net Profit$-266.0M$536.0M$883.0M$1.4B$1.9B
EPS$-0.39$0.79$1.25$1.78$2.40
Op Margin-5.3%-0.1%2.4%5.2%5.4%

Balance Sheet (USD)

Metric20222023202420252026
Total Assets$19.2B$20.7B$19.7B$21.2B$23.0B
Total Liabilities$5.1B$5.6B$5.2B$4.9B$5.2B
Cash$10.5B$10.9B$3.5B$2.2B$5.7B
Borrowings$135.0M$78.0M$82.0M$36.0M$60.0M

Latest News

Asian Penny Stock Insights For June 2026 Simply Wall St. · Jun 15, 2026 Asian Penny Stocks With Market Caps Over US$1B Simply Wall St. · May 7, 2026

Cash Flow (USD)

Metric20222023202420252026
Operating Cash Flow$424.0M$256.0M$1.1B$1.4B$1.2B
Investing Cash Flow$1.9B$-538.0M$-4.9B$-2.6B$2.0B
Financing Cash Flow$-12.0M$-69.0M$-1.9B$-39.0M$11.0M
Net Cash Flow$2.1B$-105.0M$-5.7B$-1.3B$3.2B
Free Cash Flow$409.0M$250.0M$1.1B$1.4B$1.2B

Valuation & Return Ratios

MetricValue
PEG Ratio0.25
EV / EBITDA28.97
FCF Yield3.03%
Quick Ratio2.66
Interest Coverage1357.38
Return 1Y-28.33%
Return 3Y-34.25%
Return 5Y-77.25%

Ownership

Insiders Held0.00%
Institutions Held0.00%
Institutions Float Held0.00%
Institutional HolderSharesReport Date
Old Mission Capital, LLC18,2492023-03-31

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
BDUUYBangkok Dusit Medical Services Public Company Limited $23.41 +0.00% 20.00 $9.30B 6.83%
BMXMFbioMérieux S.A. $80.31 +0.00% 20.73 $9.48B 1.41%
CHEOFCochlear Limited $78.94 -6.84% 21.25 $5.16B 3.83%
CHEOYCochlear Limited $39.03 -6.02% 21.25 $5.11B 3.89%
CHJTFCSPC Pharmaceutical Group Limited $0.98 +0.00% 21.72 $11.18B 4.08%

About Alibaba Health Information Technology Limited

Alibaba Health Information Technology Limited, an investment holding entity based in Causeway Bay, Hong Kong, manages a diverse range of operations across Mainland China and Hong Kong. Its core business revolves around pharmaceutical retail, operating an extensive e-commerce platform for health-related goods, and delivering a broad spectrum of digital healthcare services. The company directly sells a wide array of health products, including prescription and over-the-counter medications, nutritional supplements, various medical devices, and contact lenses. These are distributed to both individual consumers (B2C) and businesses (B2B) through its online storefronts on Tmall.com and a network of physical pharmacy outlets. Its e-commerce platform further offers pharmaceutical products, medical equipment, health foods, sexual health and family planning items, alongside integrated medical and healthcare services. Beyond product sales, Alibaba Health provides comprehensive medical and wellness services such as health checkups, nucleic acid testing, online consultations, appointment booking, vaccination programs, and Traditional Chinese Medicine therapies. These services are conveniently accessible via popular platforms like Taobao, Tmall, Alipay, the Dr. Deer APP, Gaode, DingTalk, and Quark. The company also engages in supply chain tracking, the provision of network hospital services, internet-based healthcare information, and technical support. Additionally, it operates internet hospitals and offers asset management services. Notably, the firm adopted its current name, Alibaba Health Information Technology Limited, in September 2014, having previously been known as CITIC 21CN Company Limited.

Alibaba Health Information Technology Limited is headquartered in HK.

Alibaba Health Information Technology Limited (ALBBY) stock trades at $8.60 with a market capitalization of $6.93B. The stock is valued at a price-to-earnings (P/E) ratio of 24.56, price-to-book of 2.68, price-to-sales of 1.39. Over the past 52 weeks the stock has ranged between $7.83 and $19.45, and currently trades 55.8% below its 52-week high.

On profitability, Alibaba Health Information Technology Limited generates a return on equity (ROE) of 10.95%, return on capital employed of 10.24%, an operating margin of 5.36%, a net profit margin of 5.65%.

Official website: www.alihealth.cn

Related Healthcare Stocks

LLY Drug Manufacturers - General $1185.71 -0.52% JNJ Drug Manufacturers - General $259.24 +0.88% ABBV Drug Manufacturers - General $246.04 +0.89% UNH Medical - Healthcare Plans $407.08 +0.77% MRK Drug Manufacturers - General $128.57 +0.16% NVS Drug Manufacturers - General $158.83 -0.64% NVO Biotechnology $51.58 +1.22% TMO Medical - Diagnostics & Research $594.00 +2.41% AMGN Drug Manufacturers - General $387.64 -1.39% ABT Medical - Devices $108.03 +0.70% GILD Drug Manufacturers - General $132.73 -1.18% PFE Drug Manufacturers - General $26.74 +2.06%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksAll stock screens
Run Stock Screener Investing Guides